Centerpoint to buy Midwest utility for $6 billion

Prothena’s lead drug has decisively failed a crucial Phase IIb study for rare, second-line cases of AL amyloidosis. And after concluding that their Phase III for frontline use is also headed to failure, the biotech’s executive team is scrapping the whole program.

CenterPoint Energy plans to buy Indiana utility Vectren Corp. for $6 billion, expanding its electric power and natural gas operations into Indiana and Ohio, it said Monday.

The Houston power company's deal to purchase Vectren's outstanding shares for $72 a piece will increase the value of CenterPoint's assets to $29 billion as it operates regulated utilities across eight states and other energy businesses in 40 states. After the acquisition is finalized, the company will have a combined 7 million customers, including CenterPoint's 2.4 million in the Houston area.

Prothena’s lead drug has decisively failed a crucial Phase IIb study for rare, second-line cases of AL amyloidosis. And after concluding that their Phase III for frontline use is also headed to failure, the biotech’s executive team is scrapping the whole program. read more

Read More Interesting News

Centerpoint to buy Midwest utility for $6 billion